Related Experiment Video
Updated: Feb 6, 2026

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal
Published on: September 12, 2025
Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations
Reema Railkar1, Piyush K Agarwal1
1Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Abstract:
There are limited treatment options for patients with recurrent non-muscle-invasive bladder cancer. In this report, we will talk about the history of photodynamic therapy; although it showed encouraging therapeutic results, it was largely abandoned due to toxicity or bystander effects on normal cells. Monoclonal antibody-conjugates represent an emerging therapeutic approach for malignancies that improves upon tumor specificity. The use of a monoclonal antibody-photosensitizer conjugate is a more selective method of delivering light therapy and has been termed "photoimmunotherapy", which we will discuss in the last part of this report.
Insights
Recurrent non-muscle-invasive bladder cancer has few treatments. Photoimmunotherapy, using targeted antibody-photosensitizer conjugates, offers a more selective approach to light-based therapy, overcoming limitations of earlier photodynamic therapy methods.
Area of Science:
- Oncology
- Biochemistry
- Immunology
Background:
- Limited treatment options exist for recurrent non-muscle-invasive bladder cancer.
- Photodynamic therapy (PDT) showed promise but was hindered by toxicity and bystander effects.
- Monoclonal antibody-conjugates offer improved tumor specificity for cancer treatment.
Purpose of the Study:
- To review the history and evolution of photodynamic therapy.
- To introduce photoimmunotherapy as an advanced targeted light-based treatment.
- To discuss the potential of monoclonal antibody-photosensitizer conjugates.
Main Methods:
- Historical review of photodynamic therapy development.
- Discussion of monoclonal antibody-conjugate technology.
- Exploration of photoimmunotherapy principles and applications.
Main Results:
- Photodynamic therapy demonstrated therapeutic potential but faced significant toxicity challenges.
- Monoclonal antibody-conjugates enhance specificity in drug delivery.
- Photoimmunotherapy combines antibody targeting with light-activated agents for selective tumor destruction.
Conclusions:
- Photoimmunotherapy represents a promising advancement over traditional photodynamic therapy for bladder cancer.
- Targeted delivery via antibody-conjugates mitigates toxicity and improves therapeutic outcomes.
- Further research into photoimmunotherapy is warranted for recurrent non-muscle-invasive bladder cancer.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Gene Therapy
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...

